Lattice Biologics Ltd.
LBLTF
$0.00
$0.000.00%
OTC PK
| 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 25.80K | 24.20K | 57.20K | 19.60K |
| Total Receivables | -- | -- | 178.20K | 289.60K | 358.30K |
| Inventory | -- | -- | 575.00K | 518.50K | 582.10K |
| Prepaid Expenses | -- | -- | 39.00K | 36.30K | 60.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | 25.80K | 816.30K | 901.60K | 1.02M |
|
|
|||||
| Total Current Assets | -- | 25.80K | 816.30K | 901.60K | 1.02M |
| Net Property, Plant & Equipment | -- | -- | 1.45M | 1.51M | 794.00K |
| Long-term Investments | 606.40K | 606.40K | 606.40K | 606.40K | 606.40K |
| Goodwill | 606.40K | 606.40K | 606.40K | 606.40K | 606.40K |
| Total Other Intangibles | -- | -- | -- | 0.00 | 57.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 606.40K | 632.30K | 2.87M | 3.02M | 2.48M |
|
|
|||||
| Total Accounts Payable | 505.70K | 1.53M | 3.47M | 3.56M | 2.83M |
| Total Accrued Expenses | -- | -- | 1.66M | 1.65M | 1.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 2.44M | 2.25M | 2.45M |
| Total Finance Division Other Current Liabilities | -- | -- | 417.10K | 373.50K | 1.20M |
| Total Other Current Liabilities | -- | -- | 417.10K | 373.50K | 1.20M |
| Total Current Liabilities | 505.70K | 1.53M | 7.99M | 7.83M | 8.05M |
|
|
|||||
| Total Current Liabilities | 505.70K | 1.53M | 7.99M | 7.83M | 8.05M |
| Long-Term Debt | -- | -- | 333.20K | 342.90K | 341.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 512.60K | 544.80K | 214.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 700.00K | 700.00K | 700.00K | 700.00K |
| Total Liabilities | 505.70K | 2.23M | 9.54M | 9.42M | 9.30M |
|
|
|||||
| Common Stock & APIC | 11.01M | 11.01M | 11.01M | 11.01M | 10.35M |
| Retained Earnings | -10.93M | -12.63M | -18.18M | -17.91M | -17.67M |
| Treasury Stock & Other | 21.90K | 21.90K | 494.20K | 494.20K | 494.20K |
| Total Common Equity | 100.70K | -1.59M | -6.67M | -6.40M | -6.83M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 100.70K | -1.59M | -6.67M | -6.40M | -6.83M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 100.70K | -1.59M | -6.67M | -6.40M | -6.83M |
|
|
|||||